Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Vaginal Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
0 drugs · 0 active trials
no drug at this stage
0 drugs · 0 active trials
no drug at this stage
Data updated 7 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Aldesleukin | Phase 2 | Phase 2 | 2 | 2 | 0 | 4 | 0 | — | — | Apr 13, 2012 |
| Nivolumab | Phase 2 | Phase 2 | 2 | 0 | 0 | 3 | 0 | — | — | Jan 30, 2017 |
| Bevacizumab | Phase 2 | Phase 2 | 1 | 0 | 0 | 2 | 0 | — | — | 2007-05 |
| Ipilimumab | Phase 2 | Phase 2 | 1 | 0 | 0 | 2 | 0 | — | — | Jan 30, 2017 |
| Atezolizumab | Phase 2 | Phase 2 | 1 | 0 | 0 | 1 | 0 | — | — | Mar 3, 2017 |
| Belzutifan | Phase 2 | Phase 2 | 1 | 1 | 0 | 1 | 0 | — | — | Dec 20, 2024 |
| Cabozantinib | Phase 2 | Phase 2 | 1 | 0 | 0 | 1 | 0 | — | — | Aug 11, 2022 |
| Durvalumab | Phase 2 | Phase 2 | 0 | 0 | 0 | 3 | 0 | — | — | Jun 1, 2018 |
| Fludarabine | Phase 2 | Phase 2 | 0 | 0 | 0 | 3 | 0 | — | — | 1999-11 |
| Cyclophosphamide | Phase 2 | Phase 2 | 0 | 0 | 0 | 2 | 0 | — | — | Apr 13, 2012 |
| Paclitaxel | Phase 2 | Phase 2 | 0 | 0 | 0 | 2 | 0 | — | — | 1994-03 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.